Lentigen Technology's Secondary Market Round

Lentigen Technology raised a round of funding on January 01, 2012. Investors include Biomark Capital.

Lentigen is a diversified biologics company focused on the development and commercialization of breakthrough treatments for human disease. Lentiviral vectors (LV), the company's technology platform, …

Articles about Lentigen Technology's Secondary Market Round: